News
20 February 2026
From Quality to Public Trust
In the healthcare industry, public trust is not built overnight. It grows through consistent quality assurance, adherence to standards, and contributions that are tangibly felt by society. As demands for transparency continue to rise, healthcare companies are expected not only to deliver good products, but also to establish accurate and…
3 February 2026
Dexa Medica Receives the 2026 BPOM Achievement Award as Indonesia’s Leading Phytopharmaceutical Company
Dexa Medica has once again affirmed its role as a pioneer in Indonesia’s pharmaceutical industry through an award presented by the National Agency of Drug and Food Control (BPOM) of the Republic of Indonesia. The BPOM Achievement Award 2026 in the category of Pioneer with the Highest Number of Phytopharmaceutical…
30 January 2026
Dexa Group’s Consistent Reputation Management Wins the 8th Indonesia Public Relations Awards
Winning the award for eight consecutive times, Dexa Group demonstrates long-term consistency in building public trust. This commitment has once again led Dexa Group to receive the Indonesia Public Relations Awards (IPRA) 2026 with the title of Best Public Relations 2026 in Public Trust Building through Ethical Pharmaceutical Practices. This…
8 July 2024
Ferron Partners with PERKENI for 2024 CVM Summit and Unveils New Diabetes Treatment
PT Ferron Par Pharmaceuticals, in collaboration with the Indonesian Society of Endocrinology (PERKENI), held the Cardio-Vascular Metabolic (CVM) Summit titled "1st Ferron CVM Summit." During the event, Ferron launched its latest anti-diabetes product, Fliptin. The event was attended by Dexa Group CEO, Mr. Ferry Soetikno; Dexa Group President Commissioner, Mrs.…
6 June 2024
Implementation of “Deal with Care”: Dexa Group Donates Ambulance to Puskesad Health Education Center
Dexa Group has enhanced its corporate value of "Deal with Care" by donating an ambulance to the Army Health Education Center (Pusdikkes Puskesad) to improve healthcare services for the community around the Pusdikkes Puskesad Hospital. Mr. V Hery Sutanto, the leader of Dexa Medica, handed over the ambulance to Colonel…
30 May 2024
Dexa Group advocates for the development of traditional herbal medicine through Indonesia Indigenous Modern Medicine in the webinar titled “Jamu: Dulu, Kini, dan Nanti.”
Indonesia's potential wealth in natural resources, as the second-largest country in terms of biodiversity, boasting over 28 thousand species of plants and 2,848 medicinal plants, presents significant opportunities for the development of natural medicine and Indonesia Indigenous Modern Medicine (OMAI) phytopharmaceuticals. Dra. Reri Indriani, Senior Expert Pharmacist and Food Supervisor…
28 May 2024
Encouraging the Development of Phytopharmaca, Dexa Group Participates in the National Jamu Week Event by BPOM.
Dexa Group is a research-based pharmaceutical company committed to actively participating in developing phytopharmaca. This commitment aligns with the government's efforts to address the dependency on imported raw materials for medicines by utilizing the country's natural resources to produce phytopharmaca. "The government provides full support for developing medicines, including natural…
17 May 2024
Stimuno Wins 14th Top Brand For Kids Award
Stimuno has once again secured the Top Brand For Kids Award, marking its 14th accolade in recognition of its unwavering commitment to quality and adherence to halal production standards from beginning to end, ensuring its consumers' comfort and safety. Marketing Magazine and Frontier Group have bestowed the Top Brand For…
23 April 2024
Prof. Raymond Tjandrawinata, The Pioneer of Indonesia’s Indigenous Modern Medicine, Ranks Among The Top Three Pharmaceutical Scientists
Clinical and Molecular Pharmacologist Prof. Raymond Tjandrawinata of Dexa Group and Unika Atma Jaya, who also pioneers the development of Indonesia Indigenous Modern Medicine (OMAI), has achieved third place among the top pharmaceutical scientists in Indonesia. The AD Scientific Index provided this ranking based on a system that analyzes scientific…
8 April 2024
Implementation of ESG, Dexa Group Supports Research Facility at Rumah Perubahan
To encourage sustainable environment and implement Environmental, Social, and Governance (ESG) principles, Dexa Group supports research facilities at Rumah Perubahan by providing microscopes. The microscopes were presented by Dexa Group's Business Development and Scientific Affairs Director, Prof. Raymond Tjandrawinata, to the Founder of Rumah Perubahan, Prof. Rhenald Kasali on Friday,…